Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP992918priorityCriticalpatent/ECSP992918A/en
Publication of ECSP992918ApublicationCriticalpatent/ECSP992918A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La invención proporciona el uso de un compuesto de fórmula I: (gráfico), en donde R1 es una base definida por una de las fórmulas: (gráfico), R2 es hidrógeno alquil C1-C4 bromo, fluoro, cloro o yodo; o una sal farmacéuticamente aceptable de ésta para la fabricación de un medicamento para la terapia inmunossupresora del animal o ser humano.The invention provides the use of a compound of formula I: (graph), wherein R1 is a base defined by one of the formulas: (graph), R2 is hydrogen C1-C4 alkyl bromine, fluoro, chloro or iodine; or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for immunosuppressive therapy of the animal or human.
NON-PEPTIDIC INHIBITING COMPOUNDS OF THE VLA-4 DEPENDENT CELL UNION IN THE TREATMENT OF INFLAMMATORY, AUTOIMMUNE AND RESPIRATORY DISEASES; PHARMACEUTICAL COMPOSITION AND TREATMENT PROCEDURE
SUBSTITUTED DERIVATIVES OF 3H-IMIDAZOL- (4.5 B (BETA)) PIRIDINA-2-IL BENZOATES AND BENZAMIDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND APPLICATIONS